{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:47:04Z","timestamp":1773078424756,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.arcmed.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T12:34:38Z","timestamp":1319805278000},"page":"627-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Events Temporarily Associated with Anti-influenza A (H1N1) Vaccination in Mexico"],"prefix":"10.1016","volume":"42","author":[{"given":"Patricia","family":"Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Reyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesta L.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2011.10.007_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.2010.294","article-title":"CDC advisory committee recommends nearly universal influenza vaccination","volume":"303","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2011.10.007_bib2","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.arcmed.2011.10.007_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/bsp.2010.0043","article-title":"Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations","volume":"8","author":"Rambhia","year":"2010","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.arcmed.2011.10.007_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/hv.7.5.14821","article-title":"Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations","volume":"7","author":"Banzhoff","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.arcmed.2011.10.007_bib5","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.vaccine.2011.01.007","article-title":"Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition","volume":"29","author":"Choe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2011.10.007_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barre syndrome after exposure to influenza virus","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arcmed.2011.10.007_bib7","first-page":"289","article-title":"Influenza A H1N1 (2009): considerations at the time of declaring the end of the contingency in Mexico","volume":"62","author":"Sarti","year":"2010","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.arcmed.2011.10.007_bib8","doi-asserted-by":"crossref","first-page":"e11694","DOI":"10.1371\/journal.pone.0011694","article-title":"An influenza A\/H1N1\/2009 hemagglutinin vaccine produced in Escherichia coli","volume":"5","author":"Aguilar","year":"2010","journal-title":"PLoSOne"},{"key":"10.1016\/j.arcmed.2011.10.007_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.arcmed.2010.01.004","article-title":"Acceptance of a vaccine against novel influenza A (H1N1) virus among health care workers in two major cities in Mexico","volume":"40","author":"Esteves","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2011.10.007_bib10","first-page":"391","article-title":"Inmunizaci\u00f3n contra rotavirus en M\u00e9xico con vacuna oral monovalente. Evaluaci\u00f3n de los datos de dos a\u00f1os del sistema de reporte de Eventos Temporalmente Asociados a Vacunaci\u00f3n","volume":"63","author":"Reyna","year":"2011","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.arcmed.2011.10.007_bib11","first-page":"657","article-title":"Preliminary results: surveillance for Guillain-Barr\u00e9 syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine\u2013United States, 2009\u20132010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arcmed.2011.10.007_bib12","unstructured":"Eventos Temporalmente Asociados a Vacunaci\u00f3n, Manual de Procedimientos. SSA; 2002."},{"key":"10.1016\/j.arcmed.2011.10.007_bib13","first-page":"1","article-title":"Eventos supuestamente atribuidos a vacunaci\u00f3n o inmunizaci\u00f3n (ESAVI)","volume":"13","author":"Whittembury","year":"2009","journal-title":"Rev Peru Epidemiol"},{"key":"10.1016\/j.arcmed.2011.10.007_bib14","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.vaccine.2011.01.056","article-title":"Adverse events following pandemic influenza vaccine Pandemrix\u00ae reported in the French military forces\u20132009-2010","volume":"29","author":"Mayet","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2011.10.007_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Yin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.10.007_bib16","first-page":"884","article-title":"Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing","volume":"44","author":"Miao","year":"2010","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.arcmed.2011.10.007_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.33321\/cdi.2008.32.37","article-title":"Annual report: surveillance of adverse events following immunization in Australia, 2007","volume":"32","author":"Lawrence","year":"2008","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.arcmed.2011.10.007_bib18","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2011.10.007_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2010.12.008","article-title":"Spontaneous reporting of adverse events following immunization against pandemic influenza in Denmark November 2009-March 2010","volume":"29","author":"Folkenberg","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2011.10.007_bib20","first-page":"481","article-title":"Safety and epidemiological effects of the first China-made mass A (H1N1) influenza vaccination","volume":"31","author":"Ji","year":"2010","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.arcmed.2011.10.007_bib21","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440911002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440911002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:39:47Z","timestamp":1759261187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440911002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0188440911002104"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2011.10.007","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Events Temporarily Associated with Anti-influenza A (H1N1) Vaccination in Mexico","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2011.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}